{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T05:08:59Z","timestamp":1790917739979,"version":"4.1.0"},"reference-count":101,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T00:00:00Z","timestamp":1599436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["none"],"award-info":[{"award-number":["none"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Alphaviruses are members of the Togaviridae family that are mainly transmitted by arthropods such as mosquitoes. In the last decades, several alphaviruses have re-emerged, causing outbreaks worldwide. One example is the re-emergence of chikungunya virus (CHIKV) in 2004, which caused massive epidemics in the Indian Ocean region after which the virus dramatically spread to the Americas in late 2013. Besides CHIKV, other alphaviruses, such as the Ross River virus (RRV), Mayaro virus (MAYV), and Venezuelan equine encephalitis virus (VEEV), have emerged and have become a serious public health concern in recent years. Infections with the Old World alphaviruses (e.g., CHIKV, RRV) are primarily associated with polyarthritis and myalgia that can persist for months to years. On the other hand, New World alphaviruses such as VEEV cause mainly neurological disease. Despite the worldwide (re-)emergence of these viruses, there are no antivirals or vaccines available for the treatment or prevention of infections with alphaviruses. It is therefore of utmost importance to develop antiviral strategies against these viruses. We here provided an overview of the reported antiviral strategies against arthritogenic alphaviruses. In addition, we highlighted the future perspectives for the development and the proper use of such antivirals.<\/jats:p>","DOI":"10.3390\/microorganisms8091365","type":"journal-article","created":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T09:18:16Z","timestamp":1599470296000},"page":"1365","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Antiviral Strategies against Arthritogenic Alphaviruses"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9771-7312","authenticated-orcid":false,"given":"Rana","family":"Abdelnabi","sequence":"first","affiliation":[{"name":"Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Herestraat 49, 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8874-675X","authenticated-orcid":false,"given":"Leen","family":"Delang","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, Herestraat 49, 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,9,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2019.113777","article-title":"Antiviral drug discovery against arthritogenic alphaviruses: Tools and molecular targets","volume":"174","author":"Abdelnabi","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Levi, L.I., and Vignuzzi, M. (2019). Arthritogenic Alphaviruses: A Worldwide Emerging Threat?. Microorganisms, 7.","DOI":"10.3390\/microorganisms7050133"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0006919","article-title":"Chikungunya as a paradigm for emerging viral diseases: Evaluating disease impact and hurdles to vaccine development","volume":"13","author":"Rezza","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e1978","DOI":"10.1002\/rmv.1978","article-title":"The neurological complications of chikungunya virus: A systematic review","volume":"28","author":"Mehta","year":"2018","journal-title":"Rev. Med. Virol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.antiviral.2018.06.009","article-title":"Prediction and prevention of urban arbovirus epidemics: A challenge for the global virology community","volume":"156","author":"Weaver","year":"2018","journal-title":"Antiviral Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/20477724.2017.1355431","article-title":"O\u2019nyong-nyong fever: A neglected mosquito-borne viral disease","volume":"111","author":"Rezza","year":"2017","journal-title":"Pathog. Glob. Health"},{"key":"ref_7","first-page":"1","article-title":"Mayaro: An emerging viral threat?","volume":"7","author":"Monsalve","year":"2018","journal-title":"Emerg. Microbes Infect."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/mve.12322","article-title":"Transmission potential of Mayaro virus in Florida Aedes aegypti and Aedes albopictus mosquitoes","volume":"32","author":"Wiggins","year":"2018","journal-title":"Med. Vet. Entomol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Claflin, S.B., and Webb, C.E. (2015). Ross River Virus: Many Vectors and Unusual Hosts Make for an Unpredictable Pathogen. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1005070"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.micinf.2017.07.001","article-title":"Ross River virus disease clinical presentation, pathogenesis and current therapeutic strategies","volume":"19","author":"Liu","year":"2017","journal-title":"Microbes Infect."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1089\/vbz.2015.1801","article-title":"Investigation into High Barmah Forest Virus Disease Case Numbers Reported in the Northern Territory, Australia in 2012\u20132013","volume":"16","author":"Kurucz","year":"2016","journal-title":"Vector-Borne Zoonotic Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.antiviral.2015.06.017","article-title":"Towards antivirals against chikungunya virus","volume":"121","author":"Abdelnabi","year":"2015","journal-title":"Antiviral Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41586-018-0121-3","article-title":"Mxra8 is a receptor for multiple arthritogenic alphaviruses","volume":"557","author":"Zhang","year":"2018","journal-title":"Nature"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/jmv.23403","article-title":"Identification of prohibitin as a Chikungunya virus receptor protein","volume":"84","author":"Wintachai","year":"2012","journal-title":"J. Med. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/1348-0421.12230","article-title":"Assessment of flavaglines as potential chikungunya virus entry inhibitors","volume":"59","author":"Wintachai","year":"2015","journal-title":"Microbiol. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.antiviral.2011.03.182","article-title":"In vitro antiviral activity of arbidol against Chikungunya virus and characteristics of a selected resistant mutant","volume":"90","author":"Delogu","year":"2011","journal-title":"Antiviral Res."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Ho, Y.J., Wang, Y.M., Lu, J.W., Wu, T.Y., Lin, L.I., Kuo, S.C., and Lin, C.C. (2015). Suramin inhibits chikungunya virus entry and transmission. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0133511"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.antiviral.2015.06.013","article-title":"Suramin inhibits chikungunya virus replication through multiple mechanisms","volume":"121","author":"Albulescu","year":"2015","journal-title":"Antiviral Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.antiviral.2016.07.025","article-title":"Suramin treatment reduces chikungunya pathogenesis in mice","volume":"134","author":"Kuo","year":"2016","journal-title":"Antiviral Res."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Albulescu, I.C., White-Scholten, L., Tas, A., Hoornweg, T.E., Ferla, S., Kovacikova, K., Smit, J.M., Brancale, A., Snijder, E.J., and van Hemert, M.J. (2020). Suramin inhibits chikungunya virus replication by interacting with virions and blocking the early steps of infection. Viruses, 12.","DOI":"10.3390\/v12030314"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.virusres.2018.06.013","article-title":"Development of an ELISA assay for screening inhibitors against divalent metal ion dependent alphavirus capping enzyme","volume":"256","author":"Kaur","year":"2018","journal-title":"Virus Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.antiviral.2017.06.003","article-title":"Antiviral activity of [1,2,3]triazolo [4,5-d]pyrimidin-7(6H)-ones against chikungunya virus targeting the viral capping nsP1","volume":"144","author":"Gigante","year":"2017","journal-title":"Antiviral Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"31819","DOI":"10.1038\/srep31819","article-title":"The viral capping enzyme nsP1: A novel target for the inhibition of chikungunya virus infection","volume":"6","author":"Delang","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1021\/acsmedchemlett.9b00662","article-title":"Identification of 2-(4-(Phenylsulfonyl)piperazine-1-yl)pyrimidine Analogues as Novel Inhibitors of Chikungunya Virus","volume":"11","author":"Moesslacher","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e00649-20","DOI":"10.1128\/AAC.00649-20","article-title":"A novel class of chikungunya virus small molecule inhibitors that targets the viral capping machinery","volume":"64","author":"Abdelnabi","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.antiviral.2019.01.003","article-title":"Approved drugs screening against the nsP1 capping enzyme of Venezuelan equine encephalitis virus using an immuno-based assay","volume":"163","author":"Li","year":"2019","journal-title":"Antiviral Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.antiviral.2018.03.013","article-title":"Identification of small molecule inhibitors of the Chikungunya virus nsP1 RNA capping enzyme","volume":"154","author":"Feibelman","year":"2018","journal-title":"Antiviral Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e02532-19","DOI":"10.1128\/AAC.02532-19","article-title":"6\u2032-\u03b2-fluoro-homoaristeromycin and 6\u2032-fluoro-homoneplanocin A are potent inhibitors of Chikungunya virus replication through their direct effect on viral nonstructural protein 1","volume":"64","author":"Kovacikova","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/1873-3468.13642","article-title":"Inhibition of Chikungunya virus by an adenosine analog targeting the SAM-dependent nsP1 methyltransferase","volume":"594","author":"Mudgal","year":"2020","journal-title":"FEBS Lett."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved antiviral drugs over the past 50 years","volume":"29","author":"Li","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Bakar, F.A., and Ng, L.F.P. (2018). Nonstructural proteins of alphavirus\u2014Potential targets for drug development. Viruses, 10.","DOI":"10.3390\/v10020071"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"104808","DOI":"10.1016\/j.antiviral.2020.104808","article-title":"Alphavirus capsid protease inhibitors as potential antiviral agents for Chikungunya infection","volume":"179","author":"Fatma","year":"2020","journal-title":"Antiviral Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmgm.2015.01.001","article-title":"Identification of chikungunya virus nsP2 protease inhibitors using structure-base approaches","volume":"57","author":"Nguyen","year":"2015","journal-title":"J. Mol. Graph. Model."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.compbiolchem.2016.06.005","article-title":"Alphavirus protease inhibitors from natural sources: A homology modeling and molecular docking investigation","volume":"64","author":"Byler","year":"2016","journal-title":"Comput. Biol. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"7382","DOI":"10.1128\/AAC.01421-16","article-title":"Design and validation of novel chikungunya virus protease inhibitors","volume":"60","author":"Das","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejmech.2014.10.042","article-title":"Thiazolidone derivatives as inhibitors of chikungunya virus","volume":"89","author":"Jadav","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Kumar, P., Kumar, D., and Giri, R. (2019). Targeting the nsp2 cysteine protease of Chikungunya virus using FDA approved library and selected Cysteine protease inhibitors. Pathogens, 8.","DOI":"10.3390\/pathogens8030128"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.antiviral.2018.03.003","article-title":"Favipiravir as a potential countermeasure against neglected and emerging RNA viruses","volume":"153","author":"Delang","year":"2018","journal-title":"Antiviral Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1093\/jac\/dku209","article-title":"Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral","volume":"69","author":"Delang","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.antiviral.2017.09.016","article-title":"Antiviral treatment efficiently inhibits chikungunya virus infection in the joints of mice during the acute but not during the chronic phase of the infection","volume":"149","author":"Abdelnabi","year":"2017","journal-title":"Antiviral Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e01389-18","DOI":"10.1128\/AAC.01389-18","article-title":"Beyond members of the Flaviviridae family, sofosbuvir also inhibits chikungunya virus replication","volume":"63","author":"Ferreira","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"46923","DOI":"10.1074\/jbc.M207847200","article-title":"Alphavirus 6K proteins form ion channels","volume":"277","author":"Melton","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Dey, D., Siddiqui, S.I., Mamidi, P., Ghosh, S., Kumar, C.S., Chattopadhyay, S., Ghosh, S., and Banerjee, M. (2019). The effect of amantadine on an ion channel protein from Chikungunya virus. PLoS Negl. Trop. Dis., 13.","DOI":"10.1371\/journal.pntd.0007548"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00705-019-04172-6","article-title":"Expression, purification and virucidal activity of two recombinant isoforms of phospholipase A 2 from Crotalus durissus terrificus venom","volume":"164","author":"Russo","year":"2019","journal-title":"Arch. Virol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Campos, D., Navarro, S., Llamas-Gonz\u00e1lez, Y.Y., Sugasti, M., and Gonz\u00e1lez-Santamar\u00eda, J. (2020). Broad antiviral activity of ginkgolic acid against chikungunya, Mayaro, una, and Zika viruses. Viruses, 12.","DOI":"10.3390\/v12040449"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.1038\/s41598-020-65357-7","article-title":"In vitro Studies on The Inhibition of Replication of Zika and Chikungunya Viruses by Dolastane Isolated from Seaweed Canistrocarpus cervicornis","volume":"10","author":"Rabelo","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"9805","DOI":"10.1038\/s41598-018-27855-7","article-title":"Co-protoporphyrin IX and Sn-protoporphyrin IX inactivate Zika, Chikungunya and other arboviruses by targeting the viral envelope","volume":"8","author":"Neris","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Bernard, E., Solignat, M., Gay, B., Chazal, N., Higgs, S., Devaux, C., and Briant, L. (2010). Endocytosis of chikungunya virus into mammalian cells: Role of clathrin and early endosomal compartments. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0011479"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/jmv.21663","article-title":"Assessment of in vitro prophylactic and therapeutic efficacy of chloroquine against Chikungunya virus in Vero cells","volume":"82","author":"Khan","year":"2010","journal-title":"J. Med. Virol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e02227-16","DOI":"10.1128\/AAC.02227-16","article-title":"Obatoclax inhibits alphavirus membrane fusion by neutralizing the acidic environment of endocytic compartments","volume":"61","author":"Varghese","year":"2016","journal-title":"Antimicrob Agents Chemother."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/art.38221","article-title":"Effectiveness of chloroquine and inflammatory cytokine response in patients with early persistent musculoskeletal pain and arthritis following chikungunya virus infection","volume":"66","author":"Chopra","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1074\/jbc.M110.198002","article-title":"Envelope lipid-packing as a critical factor for the biological activity and stability of alphavirus particles isolated from mammalian and mosquito cells","volume":"286","author":"Sousa","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/0-306-46824-7_11","article-title":"Specific roles for lipids in virus fusion and exit. Examples from the alphaviruses","volume":"34","author":"Kielian","year":"2000","journal-title":"Subcell. Biochem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"104642","DOI":"10.1016\/j.antiviral.2019.104642","article-title":"Fatty acid synthase and stearoyl-CoA desaturase-1 are conserved druggable cofactors of Old World Alphavirus genome replication","volume":"172","author":"Bakhache","year":"2019","journal-title":"Antiviral Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/s41598-020-58468-8","article-title":"Evaluation of the antiviral activity of orlistat (tetrahydrolipstatin) against dengue virus, Japanese encephalitis virus, Zika virus and chikungunya virus","volume":"10","author":"Hitakarun","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1038\/s41598-017-03316-5","article-title":"Imipramine Inhibits Chikungunya Virus Replication in Human Skin Fibroblasts through Interference with Intracellular Cholesterol Trafficking","volume":"7","author":"Wichit","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e01220-19","DOI":"10.1128\/AAC.01220-19","article-title":"Inhibition of chikungunya virus replication in primary human fibroblasts by liver X receptor agonist","volume":"63","author":"Hwang","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nchembio.790","article-title":"Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase","volume":"8","author":"Keller","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.antiviral.2018.11.017","article-title":"A potent prolyl tRNA synthetase inhibitor antagonizes Chikungunya and Dengue viruses","volume":"161","author":"Hwang","year":"2019","journal-title":"Antiviral Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.antiviral.2018.07.005","article-title":"Repurposed FDA-Approved drug sorafenib reduces replication of Venezuelan equine encephalitis virus and other alphaviruses","volume":"157","author":"Lundberg","year":"2018","journal-title":"Antiviral Res."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Henss, L., Scholz, T., Gr\u00fcnweller, A., and Schnierle, B.S. (2018). Silvestrol inhibits chikungunya virus replication. Viruses, 10.","DOI":"10.3390\/v10110592"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"ofy315","DOI":"10.1093\/ofid\/ofy315","article-title":"Rev-erb agonist inhibits chikungunya and O\u2019nyong\u2019nyong virus replication","volume":"5","author":"Hwang","year":"2018","journal-title":"Open Forum Infect. Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1128\/AAC.01467-12","article-title":"Inhibition of Chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression","volume":"57","author":"Kaur","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coviro.2015.09.005","article-title":"Interplay between the virus and the ubiquitin-proteasome system: Molecular mechanism of viral pathogenesis","volume":"17","author":"Luo","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Kaur, P., Lello, L.S., Utt, A., Dutta, S.K., Merits, A., Hann, J., and Id, C. (2020). Bortezomib inhibits chikungunya virus replication by interfering with viral protein synthesis. PLoS Negl. Trop. Dis., 14.","DOI":"10.1371\/journal.pntd.0008336"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Llamas-Gonz\u00e1lez, Y.Y., Campos, D., Pascale, J.M., Arbiza, J., and Gonz\u00e1lez-Santamar\u00eda, J. (2019). A functional ubiquitin-proteasome system is required for efficient replication of new world mayaro and una alphaviruses. Viruses, 11.","DOI":"10.3390\/v11040370"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2010.10.009","article-title":"Cellular IMPDH enzyme activity is a potential target for the inhibition of Chikungunya virus replication and virus induced apoptosis in cultured mammalian cells","volume":"89","author":"Khan","year":"2011","journal-title":"Antiviral Res."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Rothan, H.A., Bahrani, H., Mohamed, Z., Teoh, T.C., Shankar, E.M., Rahman, N.A., and Yusof, R. (2015). A Combination of Doxycycline and Ribavirin Alleviated Chikungunya Infection. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0126360"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.antiviral.2003.09.005","article-title":"In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: Synergistic effect of interferon-alpha and ribavirin combination","volume":"61","author":"Briolant","year":"2004","journal-title":"Antiviral Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e00389-19","DOI":"10.1128\/JVI.00389-19","article-title":"Atovaquone Inhibits Arbovirus Replication through the Depletion of Intracellular Nucleotides","volume":"93","author":"Grande","year":"2019","journal-title":"J. Virol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e02325-18","DOI":"10.1128\/AAC.02325-18","article-title":"Src Family Kinase Inhibitors Block Translation of Alphavirus Subgenomic mRNAs","volume":"63","author":"Broeckel","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"9","DOI":"10.12688\/f1000research.13242.1","article-title":"Miltefosine inhibits Chikungunya virus replication in human primary dermal fibroblasts","volume":"7","author":"Sharma","year":"2018","journal-title":"F1000Research"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"9743","DOI":"10.1128\/JVI.01382-16","article-title":"The antiviral alkaloid berberine reduces chikungunya virus-induced mitogen-activated protein kinase (MAPK) signaling","volume":"9","author":"Varghese","year":"2016","journal-title":"J. Virol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mBio.01382-20","article-title":"Berberine chloride is an alphavirus inhibitor that targets nucleocapsid assembly","volume":"11","author":"Wan","year":"2020","journal-title":"MBio"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.antiviral.2016.12.020","article-title":"Protein kinases C as potential host targets for the inhibition of chikungunya virus replication","volume":"139","author":"Abdelnabi","year":"2017","journal-title":"Antiviral Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bcp.2016.09.020","article-title":"Comparative analysis of the anti-chikungunya virus activity of novel bryostatin analogs confirms the existence of a PKC-independent mechanism","volume":"120","author":"Abdelnabi","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1099\/jgv.0.000712","article-title":"Viral dependence on cellular ion channels\u2014An emerging antiviral target?","volume":"98","author":"Hover","year":"2017","journal-title":"J. Gen. Virol."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"M\u00fcller, M., Jones, N., Todd, E., Khalid, H., Merits, A., Mankouri, J., and Tuplin, A. (2019). Replication of the Chikungunya virus genome requires cellular chloride channels. PLoS Negl. Trop. Dis., 13.","DOI":"10.1371\/journal.pntd.0007703"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Brown, R.S., Wan, J.J., and Kielian, M. (2018). The alphavirus exit pathway: What we know and what we wish we knew. Viruses, 10.","DOI":"10.3390\/v10020089"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"21899","DOI":"10.1074\/jbc.M802444200","article-title":"Inhibition of Chikungunya virus infection in cultured human muscle cells by furin inhibitors: Impairment of the maturation of the E2 surface glycoprotein","volume":"283","author":"Ozden","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e00693-16","DOI":"10.1128\/mBio.00693-16","article-title":"Antagonism of the sodium-potassium ATPase impairs chikungunya virus infection","volume":"7","author":"Ashbrook","year":"2016","journal-title":"MBio"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"8701","DOI":"10.1128\/JVI.00739-15","article-title":"Serotonin Receptor Agonist 5-Nonyloxytryptamine Alters the Kinetics of Reovirus Cell Entry","volume":"89","author":"Mainou","year":"2015","journal-title":"J. Virol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e00274-20","DOI":"10.1128\/JVI.00274-20","article-title":"Serotonergic Drugs Inhibit Chikungunya Virus Infection at Different Stages of the Cell Entry Pathway","volume":"94","author":"Bouma","year":"2020","journal-title":"J. Virol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e00841-19","DOI":"10.1128\/JVI.00841-19","article-title":"Distinct roles of interferon alpha and beta in controlling chikungunya virus replication and modulating neutrophil-mediated inflammation","volume":"94","author":"Cook","year":"2019","journal-title":"J. Virol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1093\/infdis\/jiw358","article-title":"Chikungunya Virus: In Vitro Response to Combination Therapy With Ribavirin and Interferon Alfa 2a","volume":"214","author":"Gallegos","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"11246","DOI":"10.1128\/JVI.01282-07","article-title":"Identification and Characterization of Interferon-Induced Proteins That Inhibit Alphavirus Replication","volume":"81","author":"Zhang","year":"2007","journal-title":"J. Virol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1172\/JCI63120","article-title":"Viperin restricts chikungunya virus replication and pathology","volume":"122","author":"Teng","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.26508\/lsa.201900298","article-title":"Viperin controls chikungunya virus-specific pathogenic T cell IFN\u03b3 Th1 stimulation in mice","volume":"2","author":"Carissimo","year":"2019","journal-title":"Life Sci. Alliance"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1126\/science.169.3951.1213","article-title":"Tilorone hydrochloride: An orally active antiviral agent","volume":"169","author":"Krueger","year":"1970","journal-title":"Science"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e00440-20","DOI":"10.1128\/AAC.00440-20","article-title":"Tilorone, a broad-spectrum antiviral for emerging viruses","volume":"64","author":"Ekins","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1743-422X-9-114","article-title":"Poly (I:C), an agonist of toll-like receptor-3, inhibits replication of the Chikungunya virus in BEAS-2B cells","volume":"9","author":"Li","year":"2012","journal-title":"Virol. J."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.virusres.2014.05.010","article-title":"TLR3 mediated innate immune response in mice brain following infection with Chikungunya virus","volume":"189","author":"Priya","year":"2014","journal-title":"Virus Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1615\/CritRevImmunol.v30.i6.10","article-title":"Function and regulation of retinoic acid-inducible gene-I","volume":"30","author":"Matsumiya","year":"2010","journal-title":"Crit. Rev. Immunol."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Goulet, M.L., Olagnier, D., Xu, Z., Paz, S., Belgnaoui, S.M., Lafferty, E.I., Janelle, V., Arguello, M., Paquet, M., and Ghneim, K. (2013). Systems Analysis of a RIG-I Agonist Inducing Broad Spectrum Inhibition of Virus Infectivity. PLoS Pathog., 9.","DOI":"10.1371\/annotation\/8fa70b21-32e7-4ed3-b397-ab776b5bbf30"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1128\/JVI.03114-13","article-title":"Inhibition of Dengue and Chikungunya Virus Infections by RIG-I-Mediated Type I Interferon-Independent Stimulation of the Innate Antiviral Response","volume":"88","author":"Olagnier","year":"2014","journal-title":"J. Virol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e01913-17","DOI":"10.1128\/JVI.01913-17","article-title":"Emerging Alphaviruses Are Sensitive to Cellular States Induced by a Novel Small-Molecule Agonist of the STING Pathway","volume":"92","author":"Gall","year":"2018","journal-title":"J. Virol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"8063","DOI":"10.1128\/JVI.00224-15","article-title":"Pentosan Polysulfate: A Novel Glycosaminoglycan-Like Molecule for Effective Treatment of Alphavirus-Induced Cartilage Destruction and Inflammatory Disease","volume":"89","author":"Herrero","year":"2015","journal-title":"J. Virol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e01959-17","DOI":"10.1128\/AAC.01959-17","article-title":"Prophylactic antiheparanase activity by PG545 is antiviral in vitro and protects against Ross River virus disease in mice","volume":"62","author":"Supramaniam","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1603\/033.046.0228","article-title":"Effects of Infectious Virus Dose and Bloodmeal Delivery Method on Susceptibility of Aedes aegypti and Aedes albopictus to Chikungunya Virus","volume":"46","author":"Pesko","year":"2009","journal-title":"J. Med. Entomol."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Sissoko, D., Malvy, D., Ezzedine, K., Renault, P., Moscetti, F., Ledrans, M., and Pierre, V. (2009). Post-epidemic Chikungunya disease on reunion island: Course of rheumatic manifestations and associated factors over a 15-month period. PLoS Negl. Trop. Dis., 3.","DOI":"10.1371\/journal.pntd.0000389"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"201611391","DOI":"10.1073\/pnas.1611391113","article-title":"How social structures, space, and behaviors shape the spread of infectious diseases using chikungunya as a case study","volume":"113","author":"Salje","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/8\/9\/1365\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:07:26Z","timestamp":1760177246000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/8\/9\/1365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,7]]},"references-count":101,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["microorganisms8091365"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms8091365","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,7]]}}}